Fresenius Medical Care AG (FMS) Depreciation & Amortization (CF) (2009 - 2025)

Fresenius Medical Care AG (FMS) has reported Depreciation & Amortization (CF) for 17 consecutive years, with $434.2 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Depreciation & Amortization (CF) fell 14.82% year-over-year to $434.2 million; the TTM figure through Dec 2025 stood at $1.7 billion (down 10.27% YoY), while the FY2025 annual figure was $1.7 billion, down 6.25% from the prior year.
• Depreciation & Amortization (CF) came in at $434.2 million for Q4 2025 at Fresenius Medical Care AG, up from $417.7 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $556.7 million in Q1 2024, with the low at $401.7 million in Q3 2024.
• Average Depreciation & Amortization (CF) over 5 years is $466.2 million, with a median of $470.1 million recorded in 2022.
• Across the five-year window, Depreciation & Amortization (CF) slipped 27.83% in 2021 and advanced 18.47% in 2024, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $499.9 million in 2021, then rose by 1.02% to $505.0 million in 2022, then fell by 9.24% to $458.4 million in 2023, then grew by 11.21% to $509.7 million in 2024, then declined by 14.82% to $434.2 million in 2025.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $434.2 million, $417.7 million, and $424.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.